ジーエヌアイグループ
2160
東証グロース
医薬品
ジーエヌアイグループの決算推移
損益計算書
(単位:百万円)
2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | |
---|---|---|---|---|---|---|---|---|---|---|
売上高 | 474 | 1,016 | 1,306 | 2,648 | 5,018 | 7,446 | 9,773 | 12,690 | 17,418 | 26,010 |
売上原価 | 161 | N/A | N/A | N/A | N/A | 1,050 | 1,545 | 1,600 | 2,674 | 3,579 |
売上総利益 | 313 | N/A | N/A | N/A | N/A | 6,395 | 8,227 | 11,089 | 14,744 | 22,431 |
販管費 | 864 | N/A | N/A | N/A | N/A | 4,334 | 5,180 | 7,958 | 10,965 | 15,292 |
営業利益 | -551 | N/A | N/A | N/A | N/A | 1,302 | 1,869 | 1,624 | 1,377 | 13,108 |
営業外収益 | 121 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
営業外費用 | 11 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
経常利益 | -441 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
特別利益 | 146 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
特別損失 | 0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
当期純利益 | -328 | -624 | -514 | -176 | -201 | 181 | 1,258 | 1,066 | 388 | 8,094 |
貸借対照表
(単位:百万円)
2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | |
---|---|---|---|---|---|---|---|---|---|---|
資産 | 6,762 | 6,385 | 5,818 | 15,879 | 17,331 | 20,607 | 23,219 | 30,296 | 33,906 | 62,394 |
流動資産 | 5,325 | N/A | N/A | N/A | N/A | 10,241 | 13,024 | 18,187 | 17,147 | 30,907 |
現金及び預金 | 4,950 | 3,022 | 2,599 | 4,192 | 4,869 | 7,674 | 10,322 | 14,352 | 11,049 | 21,633 |
売上債権 | 86 | N/A | N/A | N/A | N/A | 1,188 | 1,368 | 1,885 | 3,122 | 3,973 |
棚卸資産 | 220 | N/A | N/A | N/A | N/A | 806 | 934 | 1,382 | 1,693 | 2,330 |
固定資産 | 1,436 | N/A | N/A | N/A | N/A | 10,366 | 10,194 | 12,109 | 16,759 | 31,487 |
負債 | 975 | N/A | N/A | N/A | N/A | 7,511 | 10,450 | 11,030 | 14,096 | 26,341 |
流動負債 | 364 | N/A | N/A | N/A | N/A | 3,216 | 6,603 | 2,543 | 3,503 | 8,193 |
仕入債務 | 57 | N/A | N/A | N/A | N/A | 271 | 412 | 371 | 949 | 2,064 |
固定負債 | 611 | N/A | N/A | N/A | N/A | 4,295 | 3,846 | 8,487 | 10,592 | 18,147 |
純資産 | 5,786 | N/A | N/A | N/A | N/A | 13,095 | 12,769 | 19,266 | 19,810 | 36,052 |
利益剰余金 | -7,262 | N/A | N/A | N/A | N/A | -1,765 | -609 | 307 | 696 | 8,790 |
自己株式 | -1 | N/A | N/A | N/A | N/A | -1 | -1 | -1 | -1 | -16 |